428 related articles for article (PubMed ID: 19109589)
1. Phase 0 clinical studies in oncology.
Collins JM
Clin Pharmacol Ther; 2009 Feb; 85(2):204-7. PubMed ID: 19109589
[No Abstract] [Full Text] [Related]
2. CT2--the clinical trials control tower: overcoming barriers to opening oncology clinical trials.
Hammond AL; Waller EK; Finkelstein LB
J Clin Oncol; 2007 Apr; 25(10):1288; author reply 1288. PubMed ID: 17401022
[No Abstract] [Full Text] [Related]
3. Incorporation of geriatric principles in oncology clinical trials.
Hurria A
J Clin Oncol; 2007 Dec; 25(34):5350-1. PubMed ID: 18048814
[No Abstract] [Full Text] [Related]
4. Good news.
Block KI
Integr Cancer Ther; 2012 Dec; 11(4):291-2. PubMed ID: 23160254
[No Abstract] [Full Text] [Related]
5. [Active studies of the Working Association for Urological Oncology (AUO) in 2006].
Rexer H
Urologe A; 2006 Feb; 45(2):229-40. PubMed ID: 16440204
[No Abstract] [Full Text] [Related]
6. The changing landscape of urologic oncology: initiating systemic therapies, interventional skills, and clinical trials. Introduction.
Lin DW; Shore ND
Urol Oncol; 2012; 30(4 Suppl):S1. PubMed ID: 22795074
[No Abstract] [Full Text] [Related]
7. Future of clinical genomics in pediatric oncology.
Janeway KA; Place AE; Kieran MW; Harris MH
J Clin Oncol; 2013 May; 31(15):1893-903. PubMed ID: 23589558
[TBL] [Abstract][Full Text] [Related]
8. The ethics of phase 0 oncology trials.
Abdoler E; Taylor H; Wendler D
Clin Cancer Res; 2008 Jun; 14(12):3692-7. PubMed ID: 18559585
[TBL] [Abstract][Full Text] [Related]
9. Quality-of-life outcomes in oncology.
Siddiqui F; Kachnic LA; Movsas B
Hematol Oncol Clin North Am; 2006 Feb; 20(1):165-85. PubMed ID: 16580562
[TBL] [Abstract][Full Text] [Related]
10. Key clinical trials in gynaecological oncology.
Morrison J; Kehoe S
Eur J Surg Oncol; 2006 Oct; 32(8):887-91. PubMed ID: 16677796
[TBL] [Abstract][Full Text] [Related]
11. Targeted therapies: cui prodest?
Ferrari D; Foa P
J Clin Oncol; 2007 Oct; 25(29):4691-2; author reply 4692. PubMed ID: 17925568
[No Abstract] [Full Text] [Related]
12. Testing the wrong hypothesis in phase II oncology trials: there is a better alternative.
Ratain MJ; Karrison TG
Clin Cancer Res; 2007 Feb; 13(3):781-2. PubMed ID: 17289865
[No Abstract] [Full Text] [Related]
13. Processes to activate phase III clinical trials in a cooperative oncology group: the elephant is monstrous.
Steensma DP
J Clin Oncol; 2007 Mar; 25(9):1148; author reply 1148-9. PubMed ID: 17369584
[No Abstract] [Full Text] [Related]
14. 2015 ASCO Annual Meeting.
Coburn C
Lancet Oncol; 2015 Jul; 16(7):755-6. PubMed ID: 26062778
[No Abstract] [Full Text] [Related]
15. [Personalized medicine in oncology: from hope to reality].
Besse B; Soria JC
Rev Prat; 2012 Feb; 62(2):245-6. PubMed ID: 22408877
[No Abstract] [Full Text] [Related]
16. The chemoprevention of cancer: directions for the future.
Daly MB
Cancer Epidemiol Biomarkers Prev; 1993; 2(6):509-12. PubMed ID: 8268765
[No Abstract] [Full Text] [Related]
17. Introduction to special issue on biomarker-based clinical trial designs in oncology.
Sargent DJ; Mandrekar S; Grothey A
Chin Clin Oncol; 2015 Sep; 4(3):28. PubMed ID: 26408295
[No Abstract] [Full Text] [Related]
18. Where adolescents and young adults with cancer receive their care: does it matter?
Pollock BH
J Clin Oncol; 2007 Oct; 25(29):4522-3. PubMed ID: 17925546
[No Abstract] [Full Text] [Related]
19. Palliative care and oncology: growing better together.
Byock I
J Clin Oncol; 2009 Jan; 27(2):170-1. PubMed ID: 19064951
[No Abstract] [Full Text] [Related]
20. Oncology trials--the elephant in the room.
Kirk R; Hutchinson L
Nat Rev Clin Oncol; 2012 Mar; 9(4):185-6. PubMed ID: 22456332
[No Abstract] [Full Text] [Related]
[Next] [New Search]
